Progenics Pharmaceuticals News
Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index
GlobeNewswire May 17TARRYTOWN, N.Y. -- Progenics Pharmaceuticals, Inc. today announced that it has been selected for addition to the NASDAQ Biotechnology Index(R) (Nasdaq:^NBI) effective prior to market open on Monday, May ...
PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
May 17Salix Beats on Earnings
May 14Salix Beats on Earnings - Analyst Blog
Zacks May 14Salix continues to guide towards earnings of $3.37 per share on product revenues of $920 million in 2013.
Faruqi & Faruqi, LLP Launches An Investigation Against Progenics Pharmaceuticals, Inc. (PGNX) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors
Business Wire May 10Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha May 10Progenics Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript
Progenics Pharmaceuticals, Inc. (PGNX) Posts Q1 Loss of 22c/Share
Street Insider May 10Progenics Pharmaceuticals Announces First Quarter 2013 Financial Results
GlobeNewswire May 10TARRYTOWN, N.Y. -- Progenics Pharmaceuticals, Inc. today announced its results of operations for the quarter ended March 31.
Earnings Scheduled For May 10, 2013
Benzinga May 10Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PGNX | 4.31 | +0.18 | +4.36% | 220.38M |
New watchlist
